CODX | tickerfilter.com

Fundamental analysis

18%

Profitability 15%

Dept financing 4%

Liquidity 75%

Performance 10%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

5.21%

1 Month

-22.42%

3 Months

-34.36%

6 Months

-42.69%

1 Year

-33.22%

2 Year

-67.32%

Key data

Stock price

$0.72

P/E Ratio

-1.18

DAY RANGE

$0.72 - $1.28

EPS

-$1.27

52 WEEK RANGE

$0.75 - $2.23

52 WEEK CHANGE

-$45.92

MARKET CAP

44.356 M

YIELD

N/A

SHARES OUTSTANDING

31.911 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

11/07/2024

BETA

1.34

PUBLIC FLOAT

AVERAGE 10 VOLUME

$216,725

AVERAGE 30 VOLUME

$181,719

Company detail

CEO: Dwight H. Egan
Region: US
Website: codiagnostics.com
Employees: 100
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Co-Diagnostics, Inc. develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and analysis of nucleic acid molecules. Company also provides tests that identify genetic traits in plant and animal genomes. Company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

CODX - Co-Diagnostics, Inc.